Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Deloitte
Mallinckrodt
Fuji
Medtronic
Harvard Business School
Cantor Fitzgerald
Chinese Patent Office
McKesson
Chubb

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050733

« Back to Dashboard
NDA 050733 describes ZITHROMAX, which is a drug marketed by Pfizer and is included in seven NDAs. It is available from thirteen suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the ZITHROMAX profile page.

The generic ingredient in ZITHROMAX is azithromycin. There are thirty-two drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the azithromycin profile page.

Summary for NDA: 050733

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 050733

Ingredient-typeMacrolides

Suppliers and Packaging for NDA: 050733

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZITHROMAX
azithromycin
INJECTABLE;INJECTION 050733 NDA Pfizer Laboratories Div Pfizer Inc 0069-0400 0069-0400-10 10 VIAL in 1 CARTON (0069-0400-10) > 5 mL in 1 VIAL (0069-0400-01)
ZITHROMAX
azithromycin
INJECTABLE;INJECTION 050733 NDA Pfizer Laboratories Div Pfizer Inc 0069-3150 0069-3150-14 10 VIAL in 1 CARTON (0069-3150-14) > 5 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:Jan 30, 1997TE:APRLD:Yes
Patent:► SubscribePatent Expiration:Jul 31, 2018Product Flag?Substance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Fuji
Accenture
Teva
Merck
AstraZeneca
Argus Health
Express Scripts
Citi
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot